Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen.

David H Walker1, Nahed Ismail, Juan P Olano

  • 1Department of Pathology, University of Texas Medical Branch, World Health OrganizationCollaborating Center for Tropical Diseases, UTMB Center for Biodefense and EmergingInfectious Diseases, Galveston, Texas 77555-0609, USA.dwalker@utmb.edu

Transactions of the American Clinical and Climatological Association
|October 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Quality consistency evaluation method of Huangjing Zanyu Capsules based on multimodal information fusion].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Same author

Antagonism of stress granules key for SARS-CoV-2 infection and pathogenesis.

bioRxiv : the preprint server for biology·2026
Same author

TRP120-dependent activation of noncanonical Wnt/NFAT signaling drives monocyte chemokine production in <i>Ehrlichia chaffeensis</i> infection.

mSphere·2026
Same author

Flea infestation and molecular detection of Rickettsia and Bartonella spp. in domestic dog-associated fleas from the inter-Andean basin of Cundinamarca, Colombia.

Medical and veterinary entomology·2026
Same author

Investigation of neglected bacterial pathogens provides molecular and serological evidence of Bartonella spp. in patients with acute undifferentiated febrile illness in Villeta, Colombia.

Parasites & vectors·2026
Same author

The Paucity of Typical Pathology: An Autopsy Series of Typhus Group Rickettsiosis-Associated Hemophagocytic Lymphohistiocytosis.

Pathogens (Basel, Switzerland)·2026
Same journal

THE GORDON WILSON MEMORIAL LECTURE.

Transactions of the American Clinical and Climatological Association·2025
Same journal

HEALTHY AGING: THE PROMISE, AND PERILS, OF GEROSCIENCE.

Transactions of the American Clinical and Climatological Association·2025
Same journal

TESTOSTERONE AND INSULIN RESISTANCE IN MEN: EVIDENCE FOR A COMPLEX BI-DIRECTIONAL RELATIONSHIP.

Transactions of the American Clinical and Climatological Association·2025
Same journal

REVISITING GLUCAGON ACTION IN DIABETES: IS IT ALL BAD?

Transactions of the American Clinical and Climatological Association·2025
Same journal

DECEASED MEMBERS 1884 THROUGH 2024.

Transactions of the American Clinical and Climatological Association·2025
Same journal

OFFICERS AND COUNCIL FALL 2025.

Transactions of the American Clinical and Climatological Association·2025
See all related articles

Ehrlichia chaffeensis causes severe illness, but early doxycycline treatment is effective. Mouse models show immune responses like T cells and antibodies are key to protection against this tick-borne bacterium.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Microbiology

Background:

  • Ehrlichia chaffeensis is an intracellular bacterium transmitted by lone star ticks, causing severe human ehrlichiosis.
  • Infection can lead to multisystem disease, including toxic shock-like syndrome, meningitis, and ARDS, with a 2.7% case-fatality rate.
  • Leukopenia, thrombocytopenia, and granuloma formation are clinical and pathological features of Ehrlichia chaffeensis infection.

Purpose of the Study:

  • To investigate the immune mechanisms underlying protective immunity and fatal ehrlichiosis.
  • To explore potential diagnostic and vaccine targets based on Ehrlichia chaffeensis proteins and glycoproteins.
  • To evaluate the efficacy of doxycycline treatment and the potential of cross-protection using different Ehrlichia species in mouse models.

Main Methods:

Related Experiment Videos

  • Analysis of immune responses (CD4/CD8 T cells, cytokines like IFN-gamma, TNF-alpha, IL-10, and antibodies) in mouse models of ehrlichiosis.
  • Sequencing and expression of Ehrlichia chaffeensis proteins and glycoproteins for serological and vaccine development.
  • Utilizing mouse models with varying virulence Ehrlichia isolates (E. muris, Japanese tick isolate) to study disease progression and immunity.

Main Results:

  • Protective immunity involves type 1 T lymphocyte responses (CD4 and CD8), IFN-gamma, TNF-alpha, and antibodies.
  • Fatal ehrlichiosis is associated with weak CD4 T-helper responses, TNF-alpha overproduction, and high IL-10 levels.
  • Prior infection with low-virulence E. muris conferred protection against fatal ehrlichiosis, and doxycycline showed a dramatic response.

Conclusions:

  • Understanding the immune response is crucial for developing diagnostics and vaccines against Ehrlichia chaffeensis.
  • Specific immune profiles correlate with protection versus severe mortality, offering targets for therapeutic intervention.
  • Doxycycline remains a highly effective treatment for acute Ehrlichia chaffeensis infections, and cross-protection strategies show promise.